Protease inhibitors: resistance, resistance, resistance.

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Protease inhibitors: resistance, resistance, resistance.

GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies - 1 Feb 1997

Gilden D, Falkenberg J, Torres G

Abstract excerpt

Current anti-HIV drugs are plagued by problems with development of resistance. Reports at the 4th Annual Conference on Retroviruses and Opportunistic Infections proposed various ways to use protease inhibitor-containing combinations to build a high enough genetic barrier against HIV breakthrough. Two studies confirmed that potent highly active antiretroviral therapy combination therapies can be beneficial even to...

Topics

Anti-HIV Agents
CD4 Lymphocyte Count
Drug Resistance, Microbial
Drug Therapy, Combination
HIV
HIV Infections
HIV Protease Inhibitors
Humans
Mutation
RNA, Viral
Viral Load

Source

Open in PubMed

Identifiers

PMID: 11364108

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics